Delos Capital ’s Post

DanGer Shock, an independent investigator-initiated study, is the first RCT of Impella in cardiogenic shock to complete enrollment. Learn more: https://lnkd.in/edpiM3yR

Did you know that the first documented clinical trial was conducted in 1747 by James Lind to treat scurvy? In 1747, a Scottish doctor named James Lind conducted the first known clinical trial.** He was trying to find a cure for scurvy, a common and deadly disease among sailors at the time. Lind divided 12 sailors with scurvy into six groups and gave each group a different treatment.** The group that received citrus fruits (oranges and lemons) recovered quickly! This simple experiment revolutionized our understanding of scurvy and paved the way for modern clinical trials.** We pay tribute to James Lind for his pioneering work! #jameslind #clinicaltrialshistory #scurvycure #medicalinnovation #pioneeringresearch #historyofmedicine #clinicalresearch #patientcare #healthbreakthroughs #modernclinicaltrials #ericsolutions #pharmaresearch #evidencebasedmedicine #trialdesign #scientificdiscovery #clinicaltrialscommunity

We are proud to be national partners with the American Lung Association! ✨ Our expanded national partnership boosts radon awareness, access to free radon testing, and aligns advocacy efforts to improve lung health and save lives nationwide! Radon is the leading cause of environmental cancer mortality and claims more than 21,000 American lives each year. Dangerous levels have been found in every state, and any building can contain this invisible cancer-causing gas. Exposure is preventable, but it starts with a test. "Joining forces with the leading lung health advocate amplifies our efforts to increase awareness about the dangers of radon gas exposure, with the ultimate goal of saving lives by preventing radon-induced lung cancer.” -Kyle Hoylman, Protect Environmental CEO Everyone deserves to breathe safe air! Test your homes and buildings for the leading cause of #lungcancer among nonsmokers - #radon.

New episode of The Verdict! Host Tammie Smeltz, RPLU & Kathleen Harth explore a case of deep vein thrombosis leading to pulmonary embolism. Learn about chronic conditions, risk factors and standard of care. Listen here. 👇

Did you know that 36% of patients that develop non-ventilator hospital-acquired pneumonia (NV-HAP) go on to develop sepsis?¹ Help protect your patients from sepsis by addressing pneumonia risk factors. Find out how and join our non-vent partnership program: https://bit.ly/3XLsP7o . . . References: 1. Giuliano K, Baker D. Sepsis in the Context of Nonventilator Hospital-Acquired Pneumonia. AJCC. 2020;29(1):9-14.

It's the second day of the ELA International Symposium 📑💬 Today they are concentrating on Pelizaeus-Merzbacher Disease (PMD). Dr Adeline Vanderver is the chair for the morning session which will be discussing the natural history of the disease and early trial updates. #leukodystrophy

At the Foundation Fighting Blindness, we are more than just a community—we are a family. Together, we support each other, share our stories, and work towards a brighter future. Join our family, share your story, and help us drive the future of vision research. #ShareYourVision and become a part of our mission at: https://gag.gl/Fmnnuq Video Description: The Foundation Fighting Blindness and Share Your Vision logos in the top right corner with text below that reads, “#ShareYourVision.” A blue banner with text that reads each individuals name and disease appears in the bottom left corner. [0:00 to 0:10] Brad Manning, Stargardt disease. [0:10 to 0:16] Fai Mo, retinitis pigmentosa. [0:16 to 0:23] Cassie Lotas, Macular Dystrophy. [0:23 to 0:35] Tim Smith, retinitis pigmentosa.

At the Foundation Fighting Blindness, we are more than just a community—we are a family. Together, we support each other, share our stories, and work towards a brighter future. Join our family, share your story, and help us drive the future of vision research. #ShareYourVision and become a part of our mission at: https://gag.gl/Fmnnuq Video Description: The Foundation Fighting Blindness and Share Your Vision logos in the top right corner with text below that reads, “#ShareYourVision.” A blue banner with text that reads each individuals name and disease appears in the bottom left corner. [0:00 to 0:10] Brad Manning, Stargardt disease. [0:10 to 0:16] Fai Mo, retinitis pigmentosa. [0:16 to 0:23] Cassie Lotas, Macular Dystrophy. [0:23 to 0:35] Tim Smith, retinitis pigmentosa.

Mystery Solved: ALL Vision Diseases Have The Same Root Cause Learn more https://lnkd.in/e_a3RZ3H

At the Foundation Fighting Blindness, we are more than just a community—we are a family. Together, we support each other, share our stories, and work towards a brighter future. Join our family, share your story, and help us drive the future of vision research. #ShareYourVision and become a part of our mission at: https://gag.gl/Fmnnuq Video Description: The Foundation Fighting Blindness and Share Your Vision logos in the top right corner with text below that reads, “#ShareYourVision.” A blue banner with text that reads each individuals name and disease appears in the bottom left corner. [0:00 to 0:10] Brad Manning, Stargardt disease. [0:10 to 0:16] Fai Mo, retinitis pigmentosa. [0:16 to 0:23] Cassie Lotas, Macular Dystrophy. [0:23 to 0:35] Tim Smith, retinitis pigmentosa.